Skip to Content Facebook Feature Image

China's PPI down 2.3 pct in September, narrows its fall

China

China

China

China's PPI down 2.3 pct in September, narrows its fall

2025-10-15 10:36 Last Updated At:13:27

China's producer price index (PPI), which measures costs for goods at the factory gate, went down 2.3 percent year on year in September, the National Bureau of Statistics (NBS) said Wednesday.

The decline narrowed by 0.6 percentage points from the previous month, suggesting an improvement in industrial demand amid government efforts to bolster economic growth.

On a monthly basis, the PPI held steady in September after a 2.9 percent year-on-year decrease in August, the NBS data showed.

The PPI for purchased materials by industrial producers decreased by 3.1 percent year on year, with the rate of decline narrowing by 0.9 percentage points compared to the previous month, while the month-on-month figure increased by 0.1 percent.

For the first nine months of the year, the PPI was down 2.8 percent compared to the same period in 2024 while the average purchasing prices for industrial producers fell by 3.2 percent.

Wednesday's data also showed that China's consumer price index, a main gauge of inflation, was down 0.3 percent year on year in September.

China's PPI down 2.3 pct in September, narrows its fall

China's PPI down 2.3 pct in September, narrows its fall

China on Sunday unveiled an updated version of its national medical insurance drug list and the inaugural edition of the commercial insurance innovative drug list, according to the National Healthcare Security Administration.

The updated national medical insurance drug list has added 114 drugs, among which 50 are innovative pharmaceuticals. It has incorporated certain medications that fill the gaps in basic medical insurance coverage, such as drugs for major diseases, rare diseases, and chronic conditions.

The commercial insurance innovative drug list included 19 drugs for the treatment of tumors, rare diseases, and Alzheimer's, among others.

The country's medical insurance authority has adjusted the list for eight years in a row, increasing the total number of medications to 3,253 and significantly improving coverage in key areas such as oncology, chronic diseases, mental illnesses, rare diseases, and pediatric medications.

China updates national medical insurance catalog, adds 114 new drugs

China updates national medical insurance catalog, adds 114 new drugs

Recommended Articles